AO
AONC.US American Oncology Network Inc.
- Market cap
- USD 336M
- P/E
- -
- P/B
- -
- ROE
- -21.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2024.
Is AONC.US undervalued?
Graham numberThe Graham number of American Oncology Network Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
American Oncology Network Inc. fundamental analysis
No fundamental analysis for American Oncology Network Inc. yet.
American Oncology Network Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About American Oncology Network Inc.
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services, including nut…
Full company profileAmerican Oncology Network Inc. financial statements
American Oncology Network Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | - | 725M | 944M | 1.15B | 1.28B | 1.76B |
| Gross Profit | - | 66.1M | 78.0M | 95.5M | 82.8M | 118M |
| Operating Income | - | 22.1M | 911K | 5.57M | -49.2M | -17.4M |
| EBITDA | - | 25.9M | 7.85M | 23.1M | -39.4M | 1.82M |
| Net Income | - | 22.0M | -105K | 2.59M | -5.54M | -3.97M |
| EPS | - | 0.74 | 0.00 | 0.06 | -0.83 | -0.29 |
| Balance Sheet | ||||||
| Total Assets | - | 49.0K | 248M | 326M | 374M | 470M |
| Total Liabilities | - | 24.9K | 22.3M | 264M | 304M | 362M |
| Shareholders' Equity | - | 24.2K | 313M | 62.0M | -162M | 18.8M |
| Cash & Short-term Investments | - | 25.0K | 27.4M | 36.8M | 63.9M | 72.6M |
| Total Debt | - | - | 63.7M | 127M | 128M | 147M |
| Cash Flow | ||||||
| Operating Cash Flow | -18.3M | 37.2M | -1.23M | -6.78M | -18.1M | -4.94M |
| Capital Expenditure | 11.6M | 12.2M | 8.32M | 7.19M | 12.3M | 21.0M |
| Free Cash Flow | - | 25.0M | -34.7M | -14.0M | -30.4M | -25.9M |
| Ratios | ||||||
| ROE | - | 90,834.2% | 0.0% | 4.2% | - | -21.2% |
| ROA | - | 44,766.0% | 0.0% | 0.8% | -1.5% | -0.8% |
| Net Profit Margin | - | 3.0% | 0.0% | 0.2% | -0.4% | -0.2% |
| Debt to Equity | - | - | 0.20x | 2.05x | - | 7.85x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
American Oncology Network Inc. dividends
American Oncology Network Inc. has not paid dividends in the last 6 fiscal years.
Who owns American Oncology Network Inc.
- Insiders 77.93%
- Institutions 0.00%
- Public & others 22.08%
- Shares outstanding 29.2M
- Free float 10.4M
American Oncology Network Inc. company profile
- Company name
- American Oncology Network Inc.
- Ticker
- AONC.US
- Exchange
- USA Stocks
- Listed since
- May 5, 2021
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 1,914
- Fiscal year end
- December
- Address
- 14543 Global Parkway, Fort Myers, FL, United States, 33913
- Phone
- 833 886 1725
- Website
- aoncology.com
About American Oncology Network Inc.
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services, including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
American Oncology Network Inc. management
10- Mr. Todd SchonherzCEO & Director · born 1969
- Dr. Stephen Divers M.D.Chief Medical Officer, Vice Chairman & Chairman of Advisory Board Executive Committee · born 1973
- Mr. David Afshar CPAPrincipal Accounting Officer, CFO & COO · born 1972
- Mr. Mark MochChief Information Officer
- Ms. Kristin MatisziwChief Compliance & Risk Officer
- Mr. Charlie Goddard IIGeneral Counsel
- Ms. Caroline HewittSenior Vice President of Marketing
- Ms. Terri CaseyChief Human Resources Officer
- Mr. James Gilmore Pharm.D.Chief Pharmacy & Clinical Services Officer
- Ms. Karen PilleyChief Revenue Cycle Officer